XML 94 R80.htm IDEA: XBRL DOCUMENT v3.20.4
Share-Based Compensation - Share-Based Compensation Expense (Details) - USD ($)
$ in Millions
6 Months Ended 12 Months Ended
Dec. 31, 2020
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2018
Share-Based Compensation Expense [Line Items]        
Total share-based compensation expense $ 14.9 $ 25.2 $ 33.5 $ 27.1
Cost of molecular diagnostic testing        
Share-Based Compensation Expense [Line Items]        
Total share-based compensation expense 0.6 1.2 0.8 0.7
Cost of pharmaceutical and clinical services        
Share-Based Compensation Expense [Line Items]        
Total share-based compensation expense 0.1 0.3 0.2 0.2
Research and development expense        
Share-Based Compensation Expense [Line Items]        
Total share-based compensation expense 2.4 5.0 5.4 4.3
Selling, general, and administrative expense        
Share-Based Compensation Expense [Line Items]        
Total share-based compensation expense $ 11.8 $ 18.7 $ 27.1 $ 21.9